(CCl4) at 0.4 mL every 48 h for 42 d. 18 F-labeled NGA ([ 18 F]FNGA) was synthesized and administered at a dosage of 3.7 MBq/mouse to both fibrosis mice and normal control mice. Distribution of [ 18 F]FNGA amongst organs was examined, and dynamic scanning was performed. Parameters were set up to compare the uptake of tracers by fibrotic liver and healthy liver. Serologic tests for liver function were also performed.
RESULTS
The liver function of the fibrosis model mice was significantly impaired by the use of CCl4. In the fibrosis model mice, hepatic fibrosis was verified by naked eye assessment and pathological analysis. [ 18 F]FNGA was found to predominantly accumulate in liver and kidneys in both control group (n = 21) and fibrosis group (n = 23). The liver uptake ability (LUA), peak time (Tp), and uptake rate (LUR) of [ 18 F]FNGA between healthy liver (n = 8) and fibrosis liver (n = 10) were significantly different (P < 0.05, < 0.01, and < 0.05, respectively). LUA was significantly correlated with total serum protein level (TP) (P < 0.05). Tp was significantly correlated with both TP and glucose (Glu) concentration (P < 0.05 both), and LUR was significantly correlated with both total bile acid and Glu concentration (P < 0.01 and < 0.05, respectively).
INTRODUCTION
Asialoglycoprotein receptor (ASGPR) is expressed abundantly on the surfaces of mammalian hepatic parenchymal cells but rarely on extra-hepatic cells [1] [2] [3] . It is believed that the amount of ASGPR represents the number and density of functional hepatocytes in the liver [4, 5] . Studies revealed that expression of ASGPR on hepatic cell surface decreases in both cirrhosis and obstructive jaundice patients, with more significant reduction in cirrhosis patients. Sawamura et al [6] found that cell surface expression of ASGPR is very low on hepatocyte carcinoma cells. No ASGRP expression has been found in any metastatic cancer in liver. Tomiguchi et al [7] noted that among patients with chronic active hepatitis, the decrease of ASGPR level is highly correlated with liver fibrosis and necrosis. Therefore, quantitative assessment of the ASGPR expression in liver could directly reflect liver function with a desired accuracy [8] . Technetium-99-labeled neogalactosylalbumin ( 99m Tc-NGA), a ligand with high affinity to ASGPR, was developed [9, 10] and is being applied for differential diagnosis of focal nodular hyperplasia and hepatic cancer with single photon emission computed tomography (SPECT) [11] . However, it is the analogue of NGA, technetium-labeled galactosyl human serum albumin ( 99m Tc-GSA), that became widely used in many studies due to the non-specific binding between Tc-GSA became the first approved receptor binding reagent for scintigraphy in Japan [12] . However, the sensitivity, spatial resolution, and quantitative capacity of SPECT limited its application, whereas positron emission tomography (PET) exhibited significant advantages over SPECT [13] [14] [15] . Currently, there is no study using NGA PET scan for liver function evaluation. 18 F is the most popular positron-emitting isotope for PET imaging. It has a low positron energy and proper physical half-life (110 min), which makes it suitable for in vivo study. 18 F-labeled deoxyglucose (FDG) has been applied widely in clinical diagnosis and evaluation of neoplasms. In this study, we successfully synthesized 18 F-labeled NGA, and performed a preliminary investigation on a liver fibrosis mouse model for quantitative live function analysis.
MATERIALS AND METHODS

Establishment of murine liver fibrosis model
All animal experiment protocols were approved by the Institutional Animal Care and Use Committee and carried out in accordance with guidelines of the Laboratory Animal Center of Peking Union Medical College. Female Kunming mice, 6-7 wk and 19-25 g, were obtained from Beijing Weitonglihua Experimental Animal Corporation (Beijing, China). Liver fibrosis was induced by intraperitoneal (ip) injection of 10% carbon tetrachloride oil solution (CCl4) (National Chemical Reagent Group, Beijing, China) at 0.4 mL every 48 h for 42 d [16] . 
Radiolabeling of NGA
Serological examination
Blood samples were collected through orbital bleeding from all animals at different periods after injection of [ 18 F]FNGA. Testing items included total protein (TP), albumin (ALB), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bile acid (TBA), lactate dehydrogenase (LD), cholinesterase (ChE), urea nitrogen (BUN), serum creatinine (Cr), blood glucose (Glu), total cholesterol (Tc), triglycerides (Tg), calcium ions (Ca), adenosine dehydrogenase (ADA), sodium ions (Na), potassium ions (K), prothrombin time (PT), and international normalized ratio (INR).
microPET scan
Mice were anaesthetized by chloral hydrate. Immediately after [
18 F]FNGA injection at 7.4 MBq/kg, a mouse was laid on a microPET scanner (Siemens, Germany) and serial static emission scanning was performed at 120 kV, 100 mA/s and with a 5 mm section cranial thickness. A whole-body PET emission scan was performed with 2-min acquisition per bed position using a 3-dimensional acquisition mode with 1 min interval in a total of 30 min. A second phase scanning was also performed immediately after the 30-min scan at 5 min per scan with 1 min interval for a total of 30 min. Region of interest (ROI) was drawn and the standardized uptake values (SUV) in each ROI was measured.
PET image analysis
The images were semi-quantitatively analyzed by ImageJ software of the microPET for the average SUV within the ROI. Total body radioactivity (RTotal) was measured by the entire body scan, excluding the injection spot on the tail. Parameters were set up specifically as follows, to reflect the liver capacity for tracer uptake: Liver uptake ability (LUA) was calculated as the peak radioactive value (Rp) in liver ROI divided by the RTotal; Peak time (Tp) was the time when radioactivity in ROI reaches to the Rp; Clearance index (CI) was the radioactivity in the heart ROI at the time of liver Tp divided by the radioactivity of the first scanning in the heart ROI; Liver uptake rate (LUR) was defined as LUR = [(Rp-Rt1)/RTotal]/(Tp-T1), where T1 was the point time of the first scan and Rt1 was the liver radioactivity of the first scan.
Statistical analysis
Statistical analysis was performed with SPSS 13.0 software (IBM, Chicago, IL, United States). Data were expressed as mean ± SD. Shapiro-Wilk test was employed for normal distribution data. Independent t-test was used for comparison between the groups with normal distribution, and Mann-Whitney method was used for those with abnormal distribution. Pearson or Spearman examination was applied for correlation test for normal or non-normal distribution samples, respectively.
RESULTS
Liver function in fibrosis model mice
The number of blood samples was 31 from the fibrosis mice and 29 from the control mice, with the exception of 2 fibrosis mice having failed sampling. As shown in Table 1 , liver function of the fibrosis model mice was significantly impaired by the use of CCl4 for 42 d. Laboratory tests for liver function demonstrated significant differences between the fibrosis model mice and the controls in TP, ALB, and Glu with P < 0.05, and in ALP and ChE with P < 0.01. Obvious pinkish fiber cords were observed, even with the naked eye, in the fibrosis model mice. Hepatic fibrosis was also verified by pathological analysis (data not shown) [16] .
Biological distribution of [
18 F]FNGA in mice Animals were sacrificed after injection of [ 
Effect of NGA as a PET tracer for evaluation of liver function
Parameters based on the PET images are shown in Figure 3 . The LUA was significantly lower in fibrotic liver than that in the normal liver (P < 0.05; Figure  3A ). The Tp took significantly longer in fibrotic liver to reach a peak than in the normal liver (P < 0.01; Figure  3B ). The [ 18 F]FNGA accumulating rate (LUR) of fibrotic liver was significantly slower than that of the controls (P < 0.05; Figure 3C ). No significant differences were found in CI between the two groups.
Correlation of PET parameters with the lab tests
Correlation was found between the PET parameters and serological tests including TP, TBA, and Glu (Table  2) . LUA was significantly correlated with TP, Tp was significantly correlated with both TP and Glu, and LUR was significantly correlated with both TBA and Glu, 1B). [ 18 F]FNGA was found to accumulate mainly in liver and kidney over the time of observation in both control and fibrosis model mice, except for the initial high level in blood detected at 5 min after injection.
PET scanning
Whole body scan was performed on 10 fibrosis and 8 control mice. Clear liver images were acquired without obvious interference from other abdominal organs. Figure 2A exhibits the serial images of a control mouse over a period of 30 min. The liver outline can be clearly observed at 4 min after tracer injection. The liver radioactivity reached the peak level in the control mouse at about 19 min. However, radioactivity in the fibrosis liver reached the peak much later than that in the control group. The tracer remained in the liver at a high level throughout the scanning period. In addition, a clear heart outline was presented in the early phase. In the later phase of the scanning, high tracer accumulation was found in the bladder. Very low radioactivity was detected in the brain, lung, and limbs.
The typical dynamic curves of [ Dynamic radioactivity curves from region of interest for liver and heart from positron emission tomography scanning.
with P < 0.05 in the above conditions.
DISCUSSION
Multiple methods have been applied in clinical assessment for liver function, including serological tests [18] , Child-Pugh and model for end-stage liver disease (commonly known as MELD) scoring systems, indocyanine green clearance, and medical imaging modalities like computed tomography, magnetic resonance imaging, and SPECT [19, 20] . The above-mentioned methods provide data on certain types of liver function to meet the clinical purposes for diagnosis and treatment. However, they have prominent limitations for accurate evaluation. PET has become increasingly important as a functional diagnostic tool with various applications, especially in the diagnosis and evaluation of malignant tumors. Recently, effort has been made in using PET for liver function evaluation through sophisticated calculation of 18 F-FD-Galactose clearance [21] . It requires extra invasive arterial sampling, the procedure is far from practical, and the result is not visually observational.
To the best of our knowledge, this is the first study applying [ 
Several advantages of [
18 F]FNGA were observed for this application to liver function assessment. The rapid clearance from the cardiovascular system, as well as the extended retention in the liver, minimizes the influence to liver imaging and parameter calculation. The tracer was mainly excreted through kidneys, which was an obvious difference from the 99m Tc-GSA, which is mainly excreted from the gallbladder-gastrointestinal (GGI) tract. Therefore, the imaging result would be less likely to be influenced by obstruction of the GGI tract, which could lead to more accurate liver function evaluation. However, concern has existed about the possible influence of renal function on scanning result. In this study, all animals were normal healthy, except for the induction of liver fibrosis. And, there is no known effect of CCl4 on renal function. Nevertheless, further study will be needed in animals with kidney defect.
The receptor index (LHL15 and HH15) in the 99m Tc-GSA study was widely accepted and has been taken as reference because both NGA and GSA bind to the same receptor on hepatocytes [20] . In this study, therefore, we generated CI and LUA that played similar functional roles as HH15 and LHL15, respectively. In addition, LUR, which evaluated the liver uptake rate for [
18 F]FNGA, also showed significant differences between the control and fibrotic livers, with the fibrotic liver showing a much slower rate. In addition, these parameters were found to be highly correlated with traditional liver function indicators, such as TP and TBA, suggesting that these parameters are appropriate for liver function evaluation. A: The LUA was significantly lower in fibrosis liver than that in normal liver; B: The Tp took significantly longer in fibrosis liver to reach a peak than in the normal liver; C: The LUR of fibrosis liver was significantly slower than that of the controls.
a P < 0. When liver function was impaired, blood glucose cannot be quickly converted into glycogen, thus leading to an elevated blood glucose level. In fact, some have proposed the use of an oral glucose tolerance test curve to determine the degree of liver dysfunction, tolerance for surgery, and prognosis [22] . We found that both LUR and Tp were significantly correlated with blood glucose level, suggesting that the blood glucose level indeed may indicate one of the aspects of the liver function. This is a preliminary study investigating the use of [ 
COMMENTS
Background
There are several liver function evaluation methods routinely using in the clinic, such as serological tests, Child-Pugh and model for end-stage liver disease (commonly known as MELD) scoring systems, etc. But, none of these can assess the function of any particular anatomical fraction of the liver. Asialoglycoprotein receptor (ASGPR) is expressed abundantly on the surfaces of mammalian hepatic parenchymal cells. It is believed that the amount of ASGPR represents the number and density of functional hepatocytes in the liver. A ligand with high affinity to ASGPR, neogalactosyl albumin (NGA) was developed. To date, however, there has been no study using NGA positron emission tomography (PET) scan for liver function evaluation.
Research frontiers
This is the first study applying 
Innovations and breakthroughs
This is the first study to show [ 18 F]FNGA mainly accumulated and retained in the liver, and for sufficient time for PET. Our data demonstrated that the parameters from the pharmacokinetics curve of NGA were significantly different between control and fibrosis mice. More importantly, the data was significantly correlated with the major traditional serological tests.
Applications
In the present manuscript, we have reported, for the first time, application of [ 18 F]FNGA in the evaluation of liver function in a fibrotic and normal liver animal model. Under PET/computed tomography (CT) scan, it could primarily achieve the goals that present the liver function with computerized 3-D imagining techniques. Thus, this can be an intuitive tool to design operations and may predict the risk of hepatectomy. Finally, it can also be used in other medical fields for assessing liver function.
Terminology
Neogalactosylalbumin, positron emission tomography, liver function, liver fibrosis, mouse model.
